NexgenRx Financial Overview
NexgenRx's market cap is currently C$27.95M. The company's EPS TTM is C$0.008; its P/E ratio is 24.41; NexgenRx is scheduled to report earnings on November 21, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
